Inari Medical Inc (NARI)
49.66
-0.09
(-0.18%)
USD |
NASDAQ |
Nov 22, 16:00
49.63
-0.03
(-0.06%)
After-Hours: 20:00
Inari Medical Cash from Financing (Quarterly): 2.386M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 2.386M |
June 30, 2024 | -2.753M |
March 31, 2024 | 1.015M |
December 31, 2023 | -2.41M |
September 30, 2023 | 3.467M |
June 30, 2023 | -2.352M |
March 31, 2023 | 2.466M |
December 31, 2022 | -1.689M |
September 30, 2022 | 3.88M |
June 30, 2022 | -1.595M |
March 31, 2022 | 176.54M |
December 31, 2021 | -0.62M |
Date | Value |
---|---|
September 30, 2021 | 2.993M |
June 30, 2021 | -0.514M |
March 31, 2021 | 2.214M |
December 31, 2020 | 0.226M |
September 30, 2020 | -30.53M |
June 30, 2020 | 164.40M |
March 31, 2020 | 10.02M |
December 31, 2019 | 10.02M |
September 30, 2019 | 0.178M |
June 30, 2019 | 0.0089M |
March 31, 2019 | 0.0111M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-30.53M
Minimum
Sep 2020
176.54M
Maximum
Mar 2022
16.86M
Average
1.614M
Median
Cash from Financing (Quarterly) Benchmarks
Nevro Corp | -0.354M |
Inspire Medical Systems Inc | 9.89M |
TransMedics Group Inc | 7.862M |
Electromed Inc | -4.467M |
Myomo Inc | -0.1995M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 2.712M |
Cash from Investing (Quarterly) | -34.25M |
Free Cash Flow | 1.581M |
Free Cash Flow Per Share (Quarterly) | -0.017 |
Free Cash Flow to Equity (Quarterly) | -0.995M |
Free Cash Flow to Firm (Quarterly) | -0.995M |
Free Cash Flow Yield | 0.05% |